11/01/2024 | News release | Distributed by Public on 11/01/2024 09:03
One year after the United States Pharmacopeia (USP) compounding standards became official, health system pharmacies are still working through the challenges of implementation. And it's no surprise, given the long list of required standard operating procedures designed to overhaul sterile compounding processes, practices and facilities - with additional recommendations to go above and beyond.
But Carolyn Liptak, pharmacy executive director, Center for Pharmacy Practice Excellence at Vizient, says despite the challenges, it's the right thing to do.
"USP standards are the baseline for patient safety, but they also don't limit organizations from developing best practices above and beyond these requirements," she said. "Patient safety is an ongoing effort. We can always do better."
Bruce Leavitt, assistant vice president of pharmacy consulting, agrees.
"Every pharmacist pledges to 'do no harm,'" Leavitt said. "These standards reflect that professional commitment to excellence in patient care."
Leavitt and Liptak work closely with hospitals to mitigate patient risk and help avoid mandated corrective action plans due to non-compliance with USP standards. Liptak's team focuses on staff competencies, while Leavitt's team conducts gap analyses and compliance assessments, identifying areas for improvement and immediate action.
Both agree there are three foundational USP 797: sterile compounding steps health systems can start implementing now:
"The health systems who don't complete these foundational processes are going to be at constant risk - risk for the patient, risk for the hospital and risk for the health system," Leavitt said.
Learn more about the USP standards and Vizient's pharmacy consulting opportunities.